This is a completed Phase 2 pilot study with very small enrollment (n=5) assessing only safety and tolerability of fisetin; no efficacy results are reported in this registry record.
Reported
Enrollment5
PhasePhase 2
Primary outcome measureIncidence of Treatment-Emergent Adverse Eve…